RARE: Ultragenyx Pharmaceutical Inc. Sotuvning sof marjinal rentabelligi

Ultragenyx Pharma (RARE) tovar belgisi

Ultragenyx Pharmaceutical mRNA platformalari orqali kam uchraydigan kasalliklar terapiyasi uchun yopiq ekotizimni yaratmoqda. Savdo marjalari ushbu strategiyaning samaradorligini ko'rsatmoqda, bunda -71.80 eng so'nggi metrika ko'rsatkichini ifodalaydi. Daromad tasdiqlangan molekulalarning tijoratlashtirilishi va patent himoyasiga asoslangan. Muqobil davolash usullarining yo'qligi sababli, orfan dori vositalariga bo'lgan talab doimiy ravishda yuqori va yuqori marjali bo'lib qolmoqda.

Ultragenyx Pharmaceutical (RARE) - Sotuvning sof marjinal rentabelligi 04.07.2022dan 20.11.2026gacha

Ultragenyx Pharma (RARE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning dastlabki tahlili:Ultragenyx Pharmaceutical Inc. - RARE
Ultragenyx Pharmaceutical Inc. ishlab chiqargan mahsulot

Emitentni xolis baholash uchun sof foyda marjasini tushunish muhimdir, chunki u barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin tushumdan qolgan foyda ulushini belgilaydi. O'rtacha savdo marjasini tahlil qilish orqali investor xarajatlarni boshqarish samaradorligini baholashi mumkin, bu esa kamyob kasalliklar uchun gen terapiyasi sohasidagi qimmat R&D ga ajratilgan resurslarning yuqori konsentratsiyasi tufayli Ultragenyx Pharmaceutical (RARE) uchun juda muhimdir.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX